Earkart Limited
Earkart is a HealthTech company that focuses on hearing aids and related accessories. The company offers a wide range of modern hearing devices, including Receiver-In-Canal (RIC), Invisible (IIC), Behind The-Ear (BTE), In-The-Ear (ITE), In-The-Canal (ITC), and Completely-In-Canal (CIC) models.
- Market Cap ₹ 186 Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E 60.7
- Book Value ₹
- Dividend Yield %
- ROCE 29.0 %
- ROE 31.3 %
- Face Value ₹ 10.0
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| 5.66 | 28.42 | 30.80 | |
| 5.52 | 26.79 | 27.22 | |
| Operating Profit | 0.14 | 1.63 | 3.58 |
| OPM % | 2.47% | 5.74% | 11.62% |
| 0.04 | 0.05 | 0.21 | |
| Interest | 0.01 | 0.08 | 0.36 |
| Depreciation | 0.06 | 0.15 | 0.19 |
| Profit before tax | 0.11 | 1.45 | 3.24 |
| Tax % | 0.00% | 9.66% | 5.86% |
| 0.11 | 1.31 | 3.06 | |
| EPS in Rs | 22.00 | 262.00 | 612.00 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 134% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 31% |
Balance Sheet
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| Equity Capital | 0.05 | 0.05 | 0.05 |
| Reserves | 4.72 | 6.49 | 12.97 |
| 0.27 | 1.23 | 4.02 | |
| 0.91 | 6.96 | 2.21 | |
| Total Liabilities | 5.95 | 14.73 | 19.25 |
| 0.22 | 0.25 | 1.06 | |
| CWIP | 0.00 | 0.00 | 0.00 |
| Investments | 1.46 | 0.10 | 0.19 |
| 4.27 | 14.38 | 18.00 | |
| Total Assets | 5.95 | 14.73 | 19.25 |
Cash Flows
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| -2.83 | -0.30 | -1.00 | |
| -1.78 | 0.40 | -1.29 | |
| 4.68 | 0.41 | 3.08 | |
| Net Cash Flow | 0.07 | 0.51 | 0.80 |
Ratios
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| Debtor Days | 104.47 | 60.36 | 75.13 |
| Inventory Days | 138.26 | 100.90 | 113.12 |
| Days Payable | 92.17 | 107.33 | 19.28 |
| Cash Conversion Cycle | 150.56 | 53.93 | 168.97 |
| Working Capital Days | 192.17 | 61.90 | 111.40 |
| ROCE % | 23.89% | 29.02% |
Documents
Announcements
No data available.
Annual reports
No data available.
Business Profile[1]
Earkart manufactures and distributes modern hearing aids (BTE & RIC) and accessories, trades third-party hearing aids and parts, and also supplies mobility aids (foldable walkers) and educational/therapy kits (MSIED and TLM) for children with disabilities.